Podcasts about acip

Are vaccines safe? How long have vaccines been around? What is ACIP? Is there a booster for RSV? How old is the measles vaccine? What happens at ACIP meetings? What are the latest vaccine recommendations? Sandra Fryhofer, MD, AMA's liaison to the Advisory Committee on Immunization Practices (ACIP), shares news from the most recent meeting. American Medical Association CXO Todd Unger hosts.

The FDA issues alert regarding a compounded topical finasteride; plant-based alkaloid shows improvement for smoking cessations; potential new treatment option for GERD; and the CDC's Advisory Committee on Immunization Practices make new recommendations.

Dr. Susan Kansagra, ASTHO Chief Medical Officer, outlines the recommendations from the most recent ACIP meeting; Kathleen Amos, Director of Workforce Development at the Public Health Foundation, explains how Academic Health Department Partnerships can be beneficial; and an upcoming ASTHO webinar focuses on strengthening public health risk communication. CDC Web Page: ACIP Meeting Information ASTHO Webinar: Exploring Successful Academic Health Department Partnerships ASTHO Web Page: Calendar of Events ASTHO Webinar: Don't Panic! A Panel on How to be an Effective Crisis Communicator  

In his weekly clinical update, Dr. Griffin with Vincent Racaniello rue about the continuation of the gutting of the American public health infrastructure, the continuing measles outbreak, an unreported outbreak of deadly E.coli human infections, meningococcal disease before Dr. Griffin reviews recent statistics on RSV, influenza and SARS-CoV-2 infections, the WasterwaterScan dashboard, ACIP recommended changes in guidelines for the RSV and COVID-19 vaccines, reactogenicity differences between Novavax and Pfizer COVID-19 vaccines, where to find PEMGARDA, provides information for Columbia University Irving Medical Center's long COVID treatment center, where to go for answers to your long COVID questions, long COVID interventions, effects of long COVID in children and adolescents and a list of ongoing clinical trials for long COVID treatment. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Making America Healthy Again-purging of administrators at HHS (Politico) Making America Healthy Again-purging of data (Politico) Deep cuts of the federal government (NY Times) Cutting NIH, CDC and HHS promotes chronic disease research(Washington Post) Political ideology and trust in scientists in the USA(Nature Human Behavior) US political conservatives have deep, unbudging suspicion of science, survey suggests(CIDRAP) A deadly E. coli outbreak hit 15 states, but the FDA chose not to publicize it(NBC News) Invasive meningococcal disease – Kingdom of Saudi Arabia(WHO) The essential guide to understanding the differences between hajj and umrah (Marhabahaji) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Measles booster? (Washington Post) How to stop an outbreak…….fire the experts (Washington Post) Measles cases and outbreaks (CDC Rubeola) Measles 159 in Texas…. (Texas Health and Human Services) 2025 Measles outbreak guidance (New Mexico Health) Measles and rubella weekly monitoring (Government of Canada) Measles vaccine recommendations from NYP (jpg) NAFMA: North American Free Measles agreement…..(NY Times) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Doctors' talk measles (YouTube) Measles (CDC: Measles Rubeola) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) Respiratory virus activity levels (CDC Respiratory Illnesses) 200 children die from flu (CIDRAP) Weekly surveillance report: clift notes (CDC FluView) FDA-CDC-DOD: 2025-2046 influenza vaccine composition (FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) ACIP votes to expand recommendation for Pfizer'sRSV vaccine Abrysvo® to include adults aged 50 to 59 at increased risk of disease (Pfizer) Respiratory syncytial virus and incidence of cardiovascular events: a nationwide self-controlled case series analysis (JACC Journals) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Comorbidities associated with different degrees of severity in children and young people hospitalized with acute COVID-19 (Pediatric Infectious Disease Journal) SHIELD-Utah study shows Novavax's COVID-19 vaccine induces lower reactogenicity symptoms compared to mRNA (Novavax) Interim clinical considerations for use of COVID-19 vaccines in the United States (CDC Vaccines & Immunizations) Novavax says its COVID vaccine produces fewer, milder reactions than Pfizer version(CIDRAP) US CDC advisers discuss narrower use of COVID-19 vaccines (Reuters) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Fusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) When your healthcare provider is infected/exposed with SARS-CoV-2 (CDC) Managing healthcare staffing shortages (CDC) Steroids, dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Kidney Function following COVID-19 in children and adolescents(JAMA Network Open) Cardiovascular post-acute sequelae of SARS-CoV-2 in children and adolescents: cohort study using electronic health records(Nature Communications) Great barrington declaration (gbdeclaration.org) Clinical trials: Effectiveness of transcranial direct current in patients with persistent COVID-19 with headaches and chronic pain. Home-based Brain Stimulation Treatment for Post-acute Sequelae of COVID-19 (PASC) Acupuncture for post COVID-19 Condition (Long COVID) neuropsychiatric symptoms Pain relief with integrative medicine (prime)?: feasibility of acupuncture for long COVID Electro-acupuncture for long COVID neuropsychiatric symptoms Randomised study to investigate the effectiveness of acupuncture for the relief of long COIVD-19 related fatigue (ACU-COVID) Vagus stimulation in female long COVID patients.(Vagus) Stellate ganglion block with lidocaine for the treatment of COVID-19-induced parosmia (Stella) Therapeutic updates on long COVID: Where things stand 5 years later (ID Society) Reaching out to US house representative Letters read on TWiV 1210 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Episode 188: RSV Management and PreventionDr. Sandhu and future Dr. Mohamed summarize the management of RSV and describe how to prevent it with chemoprophylaxis and vaccines. Dr Arreaza adds some comments about RSV vaccines.Written by Abdolhakim Mohamed, MSIV, Ross University School of Medicine. Comments by Ranbir Sandhu, MD, and Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.What is RSV? -The Respiratory syncytial Virus (RSV) is an enveloped, negative-sense, single-stranded RNA virus of the Orthopneumovirus genus within the Pneumoviridae family. -RSV is a major cause of acute respiratory tract infections, particularly bronchiolitis and pneumonia, in infants and young children, and it also significantly affects older adults and immunocompromised individuals. -RSV infections cause an estimated 58,000–80,000 hospitalizations among children younger than 5 years and 60,000–160,000 hospitalizations among adults older than 65 years each year.-RSV is highly contagious and spreads through respiratory droplets and direct contact with contaminated surfaces. The virus typically causes seasonal epidemics, peaking in the winter months in temperate climates and during the rainy season in tropical regions. -Virtually all children are infected with RSV by the age of two, and reinfections can occur throughout life, often with milder symptoms.-Per the 2014 Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis, from the American Academy of Pediatrics, the most common etiology of bronchiolitis is RSV. -About 97% of children are infected with RSV in the first 2 years of life, about 40% will experience lower respiratory tract infection during the initial infection. Other viruses that cause bronchiolitis include human rhinovirus, human metapneumovirus, influenza, adenovirus, coronavirus, and parainfluenza viruses.When is RSV season?-Classically, the highest incidence of infection occurs between December and March in North America. Per CDC, there were typical prepandemic RSV season patterns, but the COVID-19 pandemic disrupted RSV seasonality during 2020–2022. -Before we dive into the seasonality patterns, for context, in order to describe RSV seasonality in the US, data was gathered and analyzed from polymerase chain reaction (PCR) test results reported to the National Respiratory and Enteric Virus Surveillance System (NREVSS) during July 2017–February 2023. -Seasonal RSV epidemics were defined as the weeks during which the percentage of PCR test results that were positive for RSV was ≥3%. Per 2017–2020 data, RSV epidemics in the United States typically follow seasonal patterns, that began in October, peaked in December or January, and ended in April. -However, during 2020–21, the typical winter RSV epidemic did not occur. The 2021–22 season began in May, peaked in July, and ended in January. -The 2022–23 season started (June) and peaked (November) later than the 2021–22 season, but earlier than prepandemic seasons. CDC notes that the timing of the 2022–23 season suggests that seasonal patterns are returning toward those observed in prepandemic years, however, warn that clinicians should be aware that off-season RSV circulation might continue.Treatment of RSVSome key points of the 2014 pediatric guidelines from the American Academy of Pediatrics.-AAP strongly do not recommend beta agonists or steroids for viral associated bronchiolitis because of no significant improved outcomes. “Clinicians should not administer albuterol (or salbutamol) to infants and children with a diagnosis of bronchiolitis (Evidence Quality: B; Recommendation Strength: Strong Recommendation).”-Epinephrine is not recommended for infants and children with a diagnosis of bronchiolitis (Evidence Quality: B; Recommendation Strength: Strong Recommendation).-Nebulized hypertonic saline should not be administered to infants with a diagnosis of bronchiolitis in the emergency department (Evidence Quality: B; Recommendation Strength: Moderate Recommendation), but hypertonic saline may be administered when they are hospitalized (Evidence Quality: B; Recommendation Strength: Weak Recommendation [based on randomized controlled trials with inconsistent findings]).-Chest physiotherapy should not be used in infants and children with a diagnosis of bronchiolitis (Evidence Quality: B; Recommendation Strength: Moderate Recommendation).-Antibiotics should not be administered in bronchiolitis unless there is a concomitant bacterial infection, or a strong suspicion of one (Evidence Quality: B; Recommendation Strength: Strong Recommendation).-Oxygen therapy may not be administered if the oxyhemoglobin saturation exceeds 90% in infants and children with a diagnosis of bronchiolitis (Evidence Quality: D; Recommendation Strength: Weak Recommendation [based on low level evidence and reasoning from first principles]).-Clinicians should administer nasogastric or intravenous fluids for infants with a diagnosis of bronchiolitis who cannot maintain hydration orally (Evidence Quality: X; Recommendation Strength: Strong Recommendation).How do we prevent RSV?Infant Immuno-prophylaxis:A clinical trial in 2022 demonstrated that a single injection of nirsevimab (Beyfortus®), administered before the RSV season, protected healthy late-preterm and term infants from RSV-associated lower respiratory tract that required medical treatment. Nirsevimab is a monoclonal antibody to the RSV fusion protein that has an extended half-life.Additionally, on August 3, 2023, the Advisory Committee on Immunization Practices (ACIP) recommended nirsevimab for all infants younger than 8 months who are born during or entering their first RSV season and for infants and children between 8-19 months who are at increased risk for severe RSV disease and are entering their second RSV season. On the basis of pre-COVID-19 pandemic patterns, nirsevimab could be administered in most of the continental United States from October through the end of March.Maternal Vaccination: The CDC recommends the administration of the RSVPreF vaccine to pregnant women between 32 0/7 and 36 6/7 weeks of gestation. This vaccination aims to reduce the risk of RSV-associated lower respiratory tract infection in infants during the first 6 months of life.At this time, if a pregnant woman has already received a maternal RSV vaccine during any previous pregnancy, CDC does not recommend another dose of RSV vaccine during subsequent pregnancies.Older individuals: -Each year in the U.S., it is estimated that between 60,000 and 160,000 older adults are hospitalized and between 6,000 and 10,000 die due to RSV infection-ABRYSVO's approval will help offer older adults protection in the RSV season.-On June 26, 2024, ACIP voted to give these recommendations: all adults older than 75 years and adults between 60–74 years who are at increased risk for severe RSV disease should receive a single dose of RSV vaccine (Abrysvo®).Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:Hamid S, Winn A, Parikh R, et al. Seasonality of Respiratory Syncytial Virus — United States, 2017–2023. MMWR Morb Mortal Wkly Rep 2023;72:355–361. DOI: http://dx.doi.org/10.15585/mmwr.mm7214a1Hammitt LL, Dagan R, Yuan Y, Baca Cots M, Bosheva M, Madhi SA, Muller WJ, Zar HJ, Brooks D, Grenham A, Wählby Hamrén U, Mankad VS, Ren P, Takas T, Abram ME, Leach A, Griffin MP, Villafana T; MELODY Study Group. Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants. N Engl J Med. 2022 Mar 3;386(9):837-846. doi: 10.1056/NEJMoa2110275. PMID: 35235726.Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, Johnson DW, Light MJ, Maraqa NF, Mendonca EA, Phelan KJ, Zorc JJ, Stanko-Lopp D, Brown MA, Nathanson I, Rosenblum E, Sayles S 3rd, Hernandez-Cancio S; American Academy of Pediatrics. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014 Nov;134(5):e1474-502. doi: 10.1542/peds.2014-2742. Erratum in: Pediatrics. 2015 Oct;136(4):782. doi: 10.1542/peds.2015-2862. PMID: 25349312.CDC, per their published article Seasonality of Respiratory Syncytial Virus — United States for 2017–2023, in the United StatesWhat U.S. Obstetricians Need to Know About Respiratory Syncytial Virus.Debessai H, Jones JM, Meaney-Delman D, Rasmussen SA. Obstetrics and Gynecology. 2024;143(3):e54-e62. doi:10.1097/AOG.0000000000005492.Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged

What are some of the distinctive ways that precarious arts collectives share resources, support each other, and make art? This episode hears from artists' collectives in three countries to learn how they organize their commoning practices. The three collectives are the "-" (dash) collective in Iran (with an artist who goes by the pseudonym "M" for political reasons); Papaya Kuir, a lesbo-transfeminist collective for Latin American migrants in the Netherlands (with Mexican-born Alejandra Maria Ortiz); and Indonesian artists who practice 'nongkrong' (Angga Cipta, aka "ACip," on left in photo, and MG Pringgotono, founder of Serrum and Gudskul, on right). More on commons at www.Bollier.org.

Susan Pierce is an ex-biotech pharmaceutical specialist who left the allopathic world after a 5-car wreck that stole two decades of her family life. She was bed-bound 25 years addicted to oxycontin and 13 other prescriptions. She was a legal drug addict. Now Susan has a tv show called Eden's Living TV teaching how to heal through Nature. Susan is ITR trauma certified, EMF certified, Raindrop Therapist and Medical Freedom Advocate. She is also a CDC whistle-blower and ACIP meeting attendee.Mississippi State graduate and a martial artist. Susan is a professional writer and motivational speaker, a Cobb County Chamber of Commerce board member and a professional football player for BAMA Fire. She is the kicker #77. Contact Susan Pierce:Edens Garden TV on social media also on Bitchute & Rumble Dr. Kimberley Linert Speaker, Author, Broadcaster, Mentor, Trainer, Behavioral Optometrist Event Planners- I am available to speak at your event. Here is my media kit: https://brucemerrinscelebrityspeakers.com/portfolio/dr-kimberley-linert/ To book Dr. Linert on your podcast, television show, conference, corporate training or as an expert guest please email her at incrediblelifepodcast@gmail.com or Contact Bruce Merrin at Bruce Merrin's Celebrity Speakers at merrinpr@gmail.com 702.256.9199 Host of the Podcast Series: Incredible Life Creator Podcast Available on... Apple: https://podcasts.apple.com/us/podcast/incredible-life-creator-with-dr-kimberley-linert/id1472641267 Spotify: https://open.spotify.com/show/6DZE3EoHfhgcmSkxY1CvKf?si=ebe71549e7474663 and on 9 other podcast platforms Author of Book: "Visualizing Happiness in Every Area of Your Life" Get on Amazon: https://amzn.to/3srh6tZ Website: https://www.DrKimberleyLinert.com The Great Discovery eLearning Platform: https://thegreatdiscovery.com/kimberley l

TODAY ON THE ROBERT SCOTT BELL SHOW: Jonathan Emord, Trump's Economy Fix Could Hurt, RFK Jr. Targets Food & Pharma, Vaccine Hesitancy Investigated, Education Job Cuts, ACIP Conflicts, Factory Farms & Flu, Laurie Wheeler on Energy Healing, Solanum Nigrum, and MORE! https://robertscottbell.com/jonathan-emord-trumps-economy-fix-could-hurt-rfk-jr-targets-food-pharma-vaccine-hesitancy-investigated-education-job-cuts-acip-conflicts-factory-farms-flu-laurie-wheeler-on-energy/

It's Hump Day! Sam speaks with Tariq Habash, former senior official at the Dept. of Education under President Biden, founder & director of the organization A New Policy, to discuss the Trump administration's actions taken regarding student loans. Then, he speaks with Dr. MarkAlain Dery, infectious disease specialist, founder of community radio station 102.3 WHIV-FM, and creator of the NoiseFilter podcast, to discuss the recent measles outbreaks in Texas & New Mexico. First, Sam runs through updates on Europe's retaliatory tariffs, public backlash to Trump's handling of the economy, the House's passage of a Continuing Resolution as the fight moves to the Senate, Trump's slashing of the DOE, Trump's $100m Tesla deal, Trump's disappearing of Columbia student and permanent US resident Mahmoud Khalil, Ukraine's support for a ceasefire, the DOJ's public corruption unit, and cuts to NOAA and the EPA, before expanding on the insane debate over the GOP's “clean” Continuing Resolution, and why Senate Democrats are so willing to hand over the US government to Elon Musk. Tariq Habash then joins, first stepping back to walk through his experience working in Biden's DOE before leaving in protest at the start of last year over the President's support of Israel's ethnic cleansing of Gaza, and unpack why the internal barriers to policy work so pushed him to establishing “A New Policy.” Moving forward, Habash explores why, despite Democrats' desires, the issue of the ethnic cleansing of Gaza will not go away under Trump, with his dreams to fully redevelop the Gaza strip in his own immaged backed by his revamping of Israel's assault and a domestic crackdown (including full-on dissappearings) of pro-Palestinian activism, with the recent abduction of Mahmoud Khalil working as Trump's perfect crime to wage war on the rights of Black and Brown permanant residents – capitalizing on Democratic Leadership's commitment to genocide to minimize dissent from the opposition. Shifting to the domestic policy side of things, Tariq brings Sam through Trump's attack on the DOE, walking through the department's long history as a Civil Rights agency, before diving deep into Trump's attack on the student loan and debt relief programs, which explicitly seek to target public service workers, and folks that work with trans folks, immigrants, or Palestinians. Wrapping up, Habash looks to the devastating impact Trump's DOE cuts will have on special education in the US, and what to make of our major educational institutions fully acquiesing to the regime. Dr. MarkAlain Dery then jumps right into a clear assessment of RFK's myriad destructive actions since being named HHS Secretary, from his lack of awareness about the ongoing measles crisis, to his cancelling of ACIP, and his backing of the all-around shutdown of any federal public health communications and much of its funding. After expanding on the fundamental problem with focusing on mitigating rather than preventative care, Dr. Dery walks Sam through the importance of a public health regime when it comes to addressing large-scale health issues facing the American public, pulling from his own recent work in New Orleans, before looking toward the biggest threats he sees facing the US' weakened public health infrastructure, including the threat of an ever-mutating bird flu, and the recent bubblings of hantavirus. Wrapping up, Dr. MarkAlain Dery reemphasizes that we have the capacity to fight against these threats, despite doubts about the current administration. And in the Fun Half: Sam dives into the outcome of the Democratic Party and mainstream media's complete acquiesence to the right wing's transphobic fearmongering, with Trump's regime implementing a full scale erasure and attack on trans identity and community, looking to Rep. Keating's complete takedown of Rep. Keith Self's blantant and direct misgendering of Rep. Sarah McBride. After expanding on Trump's recent $100m commercial deal with Tesla, and diving deep into Krystal Ball's coverage of Tesla's fraud allegations out of Canada, Sam and the MR Team dive deep into Sam's debate over social security on Jubilee. Tabatha from Central Mass calls in to unpack what trans care for your child actually looks like, plus, your calls and IMs! Follow Tariq on Twitter here: https://x.com/tariqhabash_ Find out more about A New Policy here: http://www.anewpolicy.org/ Follow MarkAlain on BlueSky here: https://bsky.app/profile/thedrdery.bsky.social Find out more about WHIV-FM here: https://whivfm.org/ Check out the Noise Filter podcast here: https://www.noisefiltershow.com/ Become a member at JoinTheMajorityReport.com: https://fans.fm/majority/join Follow us on TikTok here!: https://www.tiktok.com/@majorityreportfm Check us out on Twitch here!: https://www.twitch.tv/themajorityreport Find our Rumble stream here!: https://rumble.com/user/majorityreport Check out our alt YouTube channel here!: https://www.youtube.com/majorityreportlive Gift a Majority Report subscription here: https://fans.fm/majority/gift Subscribe to the ESVN YouTube channel here: https://www.youtube.com/esvnshow Subscribe to the AMQuickie newsletter here: https://am-quickie.ghost.io/ Join the Majority Report Discord! https://majoritydiscord.com/ Get all your MR merch at our store: https://shop.majorityreportradio.com/ Get the free Majority Report App!: https://majority.fm/app Go to https://JustCoffee.coop and use coupon code majority to get 10% off your purchase! Check out today's sponsors: Nutrafol: Start your hair growth journey with Nutrafol. For a limited time, Nutrafol is offering our listeners ten dollars off your first month's subscription and free shipping when you go to https://Nutrafol.com and enter the promo code TMR. Find out why over 4,500 healthcare professionals and stylists recommend Nutrafol for healthier hair. That's https://Nutrafol.com, promo code TMR. Manukora Honey: Thanks to Manukora for supporting The Majority Report. Now, it's easier than ever to try Manukora Honey. Head to https://Manukora.com/MAJORITY to get $25 off the Starter Kit, which comes with an MGO 850+ Manuka Honey jar, 5 honey travel sticks, a wooden spoon, and a guidebook! That's https://Manukora.com/MAJORITY for $25 off your Starter Kit. Smalls Cat Food: What are you waiting for?  Give your cat the food they deserve. Head to https://smalls.com and use promo code MAJORITY at checkout for 50% off your first order PLUS free shipping!  That's the best offer you'll find but you HAVE to use my code, MAJORITY, for 50% off your first order.  One last time: That's promo code MAJORITY for 50% off your first order PLUS free shipping!  Follow the Majority Report crew on Twitter: @SamSeder @EmmaVigeland @MattLech @BradKAlsop Check out Matt's show, Left Reckoning, on Youtube, and subscribe on Patreon! https://www.patreon.com/leftreckoning Check out Matt Binder's YouTube channel: https://www.youtube.com/mattbinder Subscribe to Brandon's show The Discourse on Patreon! https://www.patreon.com/ExpandTheDiscourse Check out Ava Raiza's music here! https://avaraiza.bandcamp.com/ The Majority Report with Sam Seder - https://majorityreportradio.com/

The news around public health is shifting in recent weeks including legacy news questioning Pfizer CEO Albert Bourla about vaccine liability shields, the postponement of the CDC's ACIP meeting, state health departments no longer promoting mass vaccination, and a halt on vaccine advertising.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

Why was the flu shot meeting cancelled? Can you die from measles? Why have measles come back in the US? Why are eggs so expensive? How does bird flu spread to humans? AMA's Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, discusses the ongoing measles outbreak in Texas, USDA's bird flu response, new research on long COVID in kids, as well as the FDA canceling a flu vaccines meeting. American Medical Association CXO Todd Unger hosts.

One of humanity's frailties is our tendency to view the world through the lens of what we've seen, lived through or experienced firsthand. That's not to say we ignore things that happened in the past, but we may not give historical events equal weight or importance when compared to current events. In medicine, it's important for us to recognize the vaccine preventable diseases we combatted in the past and apply those lessons to the future. In this episode, we reflect on the improvements and discuss how vaccine technology has improved global child heath over the last century. Many current doctors have never treated some of these diseases firsthand but our three experts for this episode have. Drs. Jim Todd and Mimi Glode worked for decades at Children's Hospital Colorado in infectious diseases. Dr. Todd is professor emeritus, and Dr. Glode is professor emerita at the University of Colorado School of Medicine. Dr. Todd directed our department of epidemiology, and Dr. Glode directed our pediatrics residency program. Our third guest, Dr. Edwin Asturias, specializes in infectious diseases and is a professor of pediatrics. He helps direct our global health programs, has led many international vaccine research projects and currently serves as voting member of the advisory committee on immunization practices (ACIP). Some highlights from this episode include:  Their experiences treating patients with infections, such as chicken pox, meningitis and measles  Navigating current vaccine skepticism across the healthcare landscape  The changing attitudes of parents to toward pediatric vaccines over time   Learning how this history can help inform current infectious diseases  For more information on Children's Colorado, visit: childrenscolorado.org. 

In his weekly clinical update, Dr. Griffin and Vincent Racaniello lament about the downfall of public health from “postponement” of the advisory committee on immunization practices and the FDA VRBPAC influenza strain selection meetings to how the communication pause prevents public notice of NIH study section meetings, and withdrawal of CDC promotions for the ‘flu vaccine' before discussing the end of Ebola outbreak in Uganda, funding from Saudi Arabia for polio eradication, the continuing and growing measles outbreak in the US including misinformation from the Secretary of HHS, highly pathogenic avian flu and its economic effect, ie the cost of eggs before Dr. Griffin reviews recent statistics on RSV, influenza and SARS-CoV-2 infections, the WasterwaterScan dashboard, where to find PEMGARDA, an update of Paxlovid administration, provides information for Columbia University Irving Medical Center's long COVID treatment center, where to go for answers to your long COVID questions, long COVID interventions and FDA approval of adjuvanted Novovax COVID vaccine. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Phantom ACIP (CDC) Postponement of ACIP…..hummmm (STATNews) Influenza Strain selection VRBPAC cancelled (Reuters) How NIH funded research is impacted by government communication pause (NY Times) Can be reviewed but still no money (STATNews) Final push to end Ebola in Uganda (WHO Uganda) Saudi Arabia sponsors polio eradication effort  (GPEI))  $500 million from Saudi Arabia to immunize 370 million children against polio (CIDRAP) Measles 124 in Texas…. (Texas Health and Human Services) A Texas child who was not vaccinated has died of measles(AP News) The Measles book-(Apple Books) Measles vaccination protects against virus infection and other infections (Science) Measles deadliest sequelae (MEDPAGE TODAY) Measles cases and outbreaks (CDC Measles) Unvaccinated Child Dies of Measles in Texas Outbreak(NY Times) Texas child is first reported US measles death in a decade as outbreak hits more than 130 (Reuters) Trump's cabinet meeting: Kennedy Shocker “Not unusual”……..seriously! (YouTube) First measles death reported in Texas as Kennedy downplays the outbreak (NBC News) Measles cliff notes: symptoms timeline (Substackdn) Annual state immunization report (Texas Health and Human Services) Measles imported into Kentucky…….no tariffs? (Commonwealth of Kentucky) Egg shortage affect flu shots? (MEDPAGE TODAY) Which Came First, the Chicken Slaughter or the Egg Shortage(Wall Street Journal) Avian Influenza in Birds: Causes and How It Spreads (CDC Avian Influenza) Agriculture Secretary Brooke Rollins: My Plan to Lower Egg Prices (Wall Street Journal) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Weekly US influenza surveillance report (CDC FluView) US respiratory virus activity (CDC Respiratory Illnesses) Trump administration yanks CDC flu vaccine campaign(NPR) RSV-Network (CDC Respiratory Syncytial virus Infection) New wild to mild campaign drives key message to tame flu and reset expectations (CDC Influenza) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Effectiveness of the original monovalent messenger RNA Coronavirus Disease 2019 (COVID-19) vaccination series against hospitalization for COVID-19–Associated venous thromboembolism (JID) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Demographic variation in US outpatient hydroxychloroquine and ivermectin use during the COVID-19 pandemic (HealthAffairs) Paxlovid update (Pfizer) Infectious Disease Society guidelines for treatment and management (ID Society) Alleviation of COVID-19 symptoms and reduction in healthcare utilization among high-risk patients treated With nirmatrelvir/ritonavir (NMV/R) (CID) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) When your healthcare provider is infected/exposed with SARS-CoV-2 (CDC) Managing healthcare staffing shortages (CDC) Steroids, dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Interventions for Long COVID: A Narrative Review (Journal of General Internal Medicine) COVID-19 vaccination and odds of post–COVID-19 condition symptoms in children aged 5 to 17 Years (JAMA Network) Novavax COVID-19 vaccine, adjuvanted (FDA) Letters read on TWiV 1196 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

The widespread use of pneumococcal conjugate vaccine (PCV) in children has dramatically lowered the incidence of pneumococcal disease through direct and indirect effects. Despite this progress, pneumococcal pneumonia still leads to more than 200,000 adult hospitalizations annually in the United States. Older adults, individuals with underlying health conditions, and certain racial groups continue to experience higher rates of pneumococcal disease. Dr. John Schoen, Senior Clinical Manager of Drug Information at the Vizient Center for Pharmacy Practice Excellence, joins Program Host Stacy Lauderdale to discuss the newest adult pneumococcal vaccine, PCV21, and recent updates to age-based pneumococcal vaccine recommendations.   Guest speakers:  John Schoen, Pharm.D, BCPS Senior Clinical Manager of Drug Information Vizient Center for Pharmacy Practice Excellence   Host:  Stacy Lauderdale, Pharm.D, BCPS Associate Vice President Vizient Center for Pharmacy Practice Excellence VerifiedRx Host   Show Notes:  [01:25-02:53] Background on PCV21 [02:54-07:56] Difference between PCV20 and PCV21 [07:57-16:15] Discussing the new ACIP recommendation to move the universal age for pneumococcal vaccination from 65 years of age down to 50 years of age and older [08:31-16:15] Why a healthy 50-year-old who has no risk factors for invasive pneumococcal disease should get a pneumococcal vaccination [16:16-17:57] Summary of other changes in the most recent MMWR [17:58-19:34] What organizations consider when selecting specific pneumococcal vaccines [19:35-21:18] What's in the pipeline for  pneumococcal vaccines   Links | Resources:  Publicly available resources Previous VerifiedRx podcasts on pneumococcal vaccines: What's pneu with pneumococcal vaccines? – March 29, 2022 What's pneu part 2: pneumococcal vaccines update – February 13, 2024 January 2024 MMWR - ACIP recommendations for the use of PCV in adults ≥ 50 years of age Vizient client exclusive resources 2025 pneumococcal vaccines side-by-side comparison   Subscribe Today! Apple Podcasts Amazon Podcasts Spotify Android RSS Feed

TODAY ON THE ROBERT SCOTT BELL SHOW: Kennedy's shakes up ACIP, Celia Farber, Truth Barrier, Homeopathic Hit - Primula Veris, COVID Natural Immunity Cover-Up, Yale Study Vaccine Injury, One Health Debate, EMF Protection, Post-Surgery Hair Loss and MORE! https://robertscottbell.com/kennedys-shakes-up-acip-bell-tones-controversy-celia-farber-truth-barrier-homeopathic-hit-primula-veris-covid-natural-immunity-cover-up-yale-study-vaccine-injury-one-health-debate-e/

TODAY ON THE ROBERT SCOTT BELL SHOW: ACIP Meeting Postponed, Trump Halts Flu Campaign, Paul Barattiero, Echo Water, Echo Flask, Colon Polyps, Copper Benefits, Pandemic Divide, Darla Shine, Happy Housewives, Ty and Charlene Documentary, Sayer Ji Petition, and MORE! https://robertscottbell.com/acip-meeting-postponed-trump-halts-flu-campaign-paul-barattiero-echo-water-echo-flask-colon-polyps-copper-benefits-pandemic-divide-darla-shine-happy-housewives-ty-and-charlene-documentary-s/

The McCullough Report with Dr. Peter McCullough – Baroness Claudia von Boeselager explores the expanding ACIP childhood vaccine schedule with Dr. McCullough. Many infectious diseases vanished without vaccines, raising questions about mass immunization for treatable illnesses. Improved sanitation, nutrition, and medical care deserve credit. What role should vaccines play in modern public health?

The McCullough Report with Dr. Peter McCullough – Baroness Claudia von Boeselager explores the expanding ACIP childhood vaccine schedule with Dr. McCullough. Many infectious diseases vanished without vaccines, raising questions about mass immunization for treatable illnesses. Improved sanitation, nutrition, and medical care deserve credit. What role should vaccines play in modern public health?

In his weekly clinical update, Dr. Griffin continues his discussion of whether the mysterious respiratory illness in the Congo is malaria, and in conjunction with your host Vincent Racaniello discusses how routine childhood immunizations especially that against poliovirus are threatened by Robert F Kennedy Jr and Aaron Siri, the origin of the SAR-CoV-2 virus and retraction of Didier Raoult's research, then returns to discussing the first case of severe disease following H5N1 infection in humans and the state of California's “bird flu emergency”, the benefit of the measles vaccine, before reviewing the recent statistics on SARS-CoV-2 infection, the WasterwaterScan dashboard, how vaccination reduced hospitalization of children between 5-17 years, the ACIP recommendation for the immunocompromised, where to find PEMGARDA, information for Columbia Unversity Irving Medical Center's long COVID treatment center, long COVID in cancer patients and the physical malaises of long COVID. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Mystery disease in DRC kills mostly children (ALJAZEERA) Malaria—mysterious disease in DRC? (ALJAZEERA) Mysterious disease in DRC is severe malaria (ALJAZEERA) Confirmed first severe human H5N1 case (CIDRAP) California declares bird flu emergency (Reuters) RFK's lawyer asks FDA to revoke approval of the polio vaccine (NY Times) NO WAY! Vaccination promotes survival and health? (LANCET) 10.6 million cases of measles this year alone! (WHO) 20% rise in measles…..(NY Times) No Sars-CoV-2 relatives in Shi Zhengli's freezers (Nature) Controversial COVID study that promoted unproven treatment retracted after four-year saga (Nature) Influenza weekly surveillance report: clift notes (CDC FluView) Waste water scan for 11 pathogens (WastewaterSCan) RSV-Network (CDC Respiratory Syncytial virus Infection) US respiratory virus activity (CDC Respiratory Illnesses) COVID-19 deaths (CDC) COVID-19 national and regional trends (CDC) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) BNT162b2 XBB Vaccine for COVID-19 Among Children 5-17 Years ofAge (JAMA Network) ACIP recommendations for those over 65 years and those under 6 months who are immunocompromised (CDC MMWR) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Fusion center near you….if in NY (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Infectious Disease Society guidelines for treatment and management (ID Society) Drug interaction checker (University of Liverpool) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) When your healthcare provider is infected/exposed with SARS-CoV-2 (CDC) Managing healthcare staffing shortages (CDC) Steroids, dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) Post-acute sequelae of COVID-19 in cancer patients: Two cohorts in UK and Hong Kong(Cancer Medicine) Skeletal muscle adaptations and post-exertional malaise in long COVID (Cell: Trends in Endocrinology & Metabolism) Letters read on TWiV 1176 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

Dr. Manisha Juthani, Commissioner of the Connecticut Department of Public Health and ASTHO President-Elect, breaks down some of the recommendations from the most recent ACIP meeting; Kelsey Tillema, ASTHO Senior Analyst, discusses the recent PH-HERO Agency Advocate event; and for all PHIG information, PHIG has its own newsletter now. American Medical Association Web Page: New ACIP recommendations – COVID vaccine frequency for seniors and RSV vaccine safety concerns PHIG Newsletter ASTHO Web Page: Stay Informed  

La Ventana MetropolitanaEl portavoz de Acip denuncia al BNG de Pontearas por injurias y calumnias. Moaña aprueba el proyecto de auditorio de Sisalde y pedirá financiación a la Xunta. Redondela y O Porriño presentan su programación por el 25-N.

What are the new COVID vaccine guidelines? Is the RSV vaccine safe? When should you get the pneumococcal vaccine? Is there a vaccine for meningococcal disease? Our guest is Sandra  Fryhofer, MD, AMA's liaison to the Advisory Committee on Immunization Practices (ACIP) and a member of ACIP's COVID-19 Vaccine Workgroup. American Medical Association CXO Todd Unger hosts.

Episode: Leading the Way Through Respiratory Virus Season Host: Ghinwa Dumyati, MD, Professor of Medicine, Director of the Communicable Diseases Surveillance and Prevention Program, University of Rochester Guest(s): Kelly Langford, Online Communications Director for the Risk Less. Do More. Campaign, U.S. Department of Health and Human Services In This Episode: In this episode of PALTtalk, Dr. Ghinwa Dumyati and Kelly Langford discuss the importance of immunizations during respiratory virus season, focusing on flu, COVID-19, and RSV. They highlight the new Risk Less. Do More. campaign, which aims to reduce infection risks, especially among vulnerable populations, including older adults in long-term care facilities. Since the recording of this episode, the Advisory Committee on Immunization Practices (ACIP) released updated COVID-19 vaccination guidance for 2024-2025. In addition to the previously recommended 2024-2025 COVID-19 vaccination, ACIP now recommends a second dose of the 2024-2025 COVID-19 vaccine for adults ages 65 and older. For those who are previously unvaccinated and receiving Novavax, two doses are recommended as the initial vaccination series. This should be followed by a third dose of any age-appropriate 2024-2025 COVID-19 vaccine at least 6 months after the second dose, with a minimum interval of 2 months. Date Recorded: October 22, 2024 Resources: Risk Less. Do More. Campaign (HHS) Moving Needles Project (PALTmed and CDC) Talking with Patients About Respiratory Virus Season (CDC) Available Credit: The American Board of Post-Acute and Long-Term Care Medicine (ABPLM) issues CMD credits for select PALTtalk podcast episodes as follows: This episode is certified for CMD Clinical hours. Claim CMD Credit Support: Funding for this podcast was provided through the Risk Less. Do More. campaign from the U.S. Department of Health and Human Services.

We emerged from the COVID -19 pandemic in 2022 to headlines about unseasonably early spikes in respiratory syncytial virus and concerns and threats of a triple pandemic of CV19, influenza, and RSV.  Fortunately, there's been no triple pandemic, but what has emerged is multiple first-time vaccine approvals for RSV. Dr. John Schoen, Senior Manager of Drug Information at The Vizient Center for Phamacy Practice Excellence joins his colleague and Program Host Stacy Lauderdale, Associate Vice President of Evidence-Based Medicine to discuss the use of the RSV vaccines.   Guest speakers:  John Schoen, PharmD, BCPS Senior Manager of Drug Information  Vizient Center for Pharmacy Practice Excellence   Host: Stacy Lauderdale, PharmD, BCPS Associate Vice President of Evidence-Based Medicine  Vizient Center for Pharmacy Practice Excellence VerifiedRx Host   Show Notes:  [00:55-01:46] John's background  [01:47 -03:15] The RSV disease burden in older adults, and risk factors [03:16-04:42] The relative disease severity of RSV versus influenza [04:43-07:04] Vaccine uptake during the last RSV season [07:05-8:35] Efficacy of the RSV vaccines in observational data compared to the clinical trials [8:36-11:22] Changes in ACIP recommendations [11:23-13:14] Potential benefits of RSV vaccination for ages older than 75 [13:15-15:32] Potential adverse reactions of RSV vaccines [15:33-18:31] Comparisons of the RSV vaccines [18:32-20:46] Are patients going to need more than one RSV vaccine?   Subscribe Today! Apple Podcasts Amazon Podcasts Spotify Android RSS Feed

What is the newest COVID vaccine called? When is the new COVID vaccine available? Which COVID 19 vaccine is best? What are the CDC COVID guidelines for vaccines? Our guest is Sandra Fryhofer, MD, AMA's liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP's COVID-19 Vaccine Workgroup. American Medical Association CXO Todd Unger hosts.

In his weekly clinical update, Dr. Griffin discusses the harms of perpetuating the lab leak hypothesis and the recent ACIP recommendations for the RSV vaccine for those individuals over 60, before reviewing the recent statistics on SARS-CoV-2 infection, treatment guidelines for the different phases of COVID, including vaccines, Pemgarda, early treatment with Paxlovid, remdesivir and molnupiravir, steroids at the right time, anticoagulation support, immune modulation in some cases, and a comprehensive definition of long COVID. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Measles transmission after secondary vaccination failure (Emerg Inf Dis) Mpox public health emergency of international concern (WHO) First case of new mpox strain outside of Africa (Reuters) COVID-19 national trend (CDC) COVID-19 deaths (CDC) Where to get pemgarda (Pemgarda CDC Quarantine guidelines (CDC) Early phase of SARs-CoV-2 infection (COVID.gov) Individual monoclonal antibodies against SARS-CoV-2 should be used (CID) NIH COVID-19 treatment guidelines (NIH) Infectious Disease Society guidelines for treatment and management (ID Society) Drug interaction checker (University of Liverpool) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) Managing healthcare staffing shortages (CDC) Steroids,dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Long COVID science, research and policy (Nature Medicine) Measurements of prior SARS-CoV-2 infection and postacute sequelae by the clinical laboratory (Annals of Internal Medicine) Risk factors for long COVID syndrome in postmenopausal women with previous SARS-CoV-2 infections (Annals of Epidemiology) New studies estimate long-COVID rates, identify risk factors (CIDRAP) Monitoring long COVID via telemedicine (PLoS One) Letters read on TWiV 1140 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

In his weekly clinical update, Dr. Griffin discusses the harms of perpetuating the lab leak hypothesis and the recent ACIP recommendations for the RSV vaccine for those individuals over 60, before reviewing the recent statistics on SARS-CoV-2 infection, treatment guidelines for the different phases of COVID, including vaccines, Pemgarda, early treatment with Paxlovid, remdesivir and molnupiravir, steroids at the right time, anticoagulation support, immune modulation in some cases, and a comprehensive definition of long COVID. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Harms of the lab leak hypothesis (Journal of Virology) Lab leak mania (PaulOffit, Substack) This is a special message: pandemic started in nature! (TWiV) RSV vaccine recommendations August 6 2024 (MMWR) COVID-19 national trend (CDC) COVID-19 deaths (CDC) Where to get Pemgarda (Pemgarda) CDC Quarantine guidelines (CDC) Early phase of SARs-CoV-2 infection (COVID.gov) NIH COVID-19 treatment guidelines (NIH) Infectious Disease Society guidelines for treatment and management (ID Society) Drug interaction checker (University of Liverpool) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) Managing healthcare staffing shortages (CDC) Steroids,dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Long COVID defined (NEJM) Contribute to our Floating Doctors fundraiser Lenacapavir on Puscast #60 Letters read on TWiV 1138 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

In this episode, we're breaking down the current viral landscape, focusing on COVID-19, mpox, norovirus, bird flu, and pertussis. We will discuss the unique challenges these viruses pose to immunocompromised individuals and offer practical advice on how to stay protected from viruses during this hot summer. We also recap the recommendations from the recent ACIP meeting, the advisory committee to the CDC on vaccines. Among the highlights in this episode: 01:10: Zoe Rothblatt, Director of Community Outreach at GHLF, begins the discussion on the current state of COVID-19, noting that while cases are rising, the levels are still much lower compared to the pandemic's peak 02:11: Steven Newmark, Chief of Policy at GHLF, discusses the emergence of new COVID-19 variants and the importance of adapting vaccinations to combat these changes effectively 03:16: Our hosts talk about the specific challenges facing Hawaii, including higher COVID-19 rates possibly due to less community immunity and challenges in vaccine distribution 05:22: Zoe highlights the rise in norovirus cases and reminds listeners about the simple yet effective measure of handwashing to prevent spread 07:13: Steven updates on the latest bird flu cases, reassuring that the transmission remains from animals to humans, not between humans 08:19: The discussion shifts to the ongoing heatwave, with advice on how medications might interact with high temperatures and the importance of staying hydrated 09:53: Steven provides a summary of the latest CDC recommendations for vaccinations, including the new directives for COVID-19, RSV, and pneumococcal vaccines 11:09: What our hosts learned from this episode Contact Our Hosts Steven Newmark, Chief of Policy at GHLF: snewmark@ghlf.org Zoe Rothblatt, Director of Community Outreach at GHLF: zrothblatt@ghlf.org A podcast episode produced by Ben Blanc, Associate Director, Digital Production and Engagement at GHLF. We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.org Catch up on all our episodes on our website or on your favorite podcast channel.See omnystudio.com/listener for privacy information.

Is a new COVID vaccine coming out? Which RSV vaccine is better? Are there new PCV vaccines? Which vaccines can be given together? When is the new flu shot available? Our guest is Sandra Fryhofer, MD, AMA's liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP's COVID-19 Vaccine Workgroup. American Medical Association CXO Todd Unger hosts.

On this episode of NP Pulse: The Voice of the Nurse Practitioner®, Drs. Mary Koslap-Petraco and Ruth Carrico will discuss meningococcal disease, the maze of meningococcal vaccines, ACIP recommendations and the use of shared clinical decision-making. Meningococcal disease — a life-threatening infection caused by Neisseria meningitidis — demands our attention. It strikes swiftly, leaving devastation in its wake. Still, we have powerful tools at our disposal: MenACWY and MenB vaccines, and a new, game-changing pentavalent vaccine that covers serogroups A, B, C, W and Y. Additionally, a meningitis point-of-care tool will be available on AANP's Tools and Resources page. To earn 1.0 contact hours of continuing education (CE) credit, you will need the participation code provided at the end of the podcast. To claim your CE credit, log in and register for the activity within the AANP CE Center, then enter the participation code and complete the post-test and evaluation. CE credit is available for this podcast through June 2025. This educational activity is supported by an independent medical education grant from GSK.

Hear expert faculty answer common questions about the risk, impact, and recommendations for protection against mpox, including:Why is mpox relevant to clinical practice?Who is at highest risk for mpox?How is mpox transmitted, and what are the clinical manifestations and complications of mpox infections?What are current ACIP recommendations for mpox vaccination?What about pre- and postexposure vaccination?PresentersCarlos del Rio, MD Distinguished Professor of Medicine (Infectious Diseases)Emory University School of MedicineProfessor of Global Health and EpidemiologyRollins School of Public HealthAtlanta, GeorgiaAniruddha (Anu) Hazra, MDAssistant Professor of Medicine, Section of Infectious Disease and Global HealthDirector, Infectious Diseases Fellowship ProgramMedical Director, UCM Sexual Wellness ClinicUniversity of ChicagoChicago, IllinoisLearn more about thekey aspects of mpox infections and prevention through vaccination in our full program,“Protection Beyond Outbreaks: Routine Mpox Vaccination for Vulnerable Populations.”Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

0:16 Intro 2:29 Updated community-acquired pneumonia guidelines 5:41 Diagnostic tools for CAP following COVID-19 9:35 Procalcitonin levels as a biomarker 12:30 The CAP treatment algorithm 18:36 Best practices for antibiotic stewardship 20:40 New CAP therapies on the horizon 22:36 ACIP recommendations for vaccination 24:30 Remaining areas of CAP uncertainty 26:30 Final thoughts 27:25 Outro Featuring infectious disease expert Dr. Thomas File of Summa Health in Ohio, this episode delves into how community-acquired pneumonia has been affected by the COVID-19 pandemic. It additionally covers the role and importance of antibiotic stewardship and the concern of ‘superbugs' due to antimicrobial resistance. Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

Using common case scenarios, Robert H. Hopkins, Jr., MD, MACP, and Laura P. Hurley, MD, MPH, discuss strategies for optimizing shingles vaccine uptake, including:The pathophysiology of shingles to better understand risk and burdenCDC guidelines and ACIP shingles vaccine recommendations, including considerations for those who are immunocompromised Strategies for optimizing shingles vaccine uptake no matter the clinical settingHow to address shingles vaccine‒related adverse events Addressing insurance-related concerns Presenters:Robert H. Hopkins, Jr., MD, MACPProfessor of Internal Medicine and PediatricsChief, Division of General Internal MedicineUniversity of Arkansas for Medical SciencesSchool of MedicineLittle Rock, ArkansasLaura P. Hurley, MD, MPHGeneral Internist and Health Services ResearcherAssociate Professor of MedicineDepartment of General Internal MedicineUniversity of Colorado Anschutz Medical CampusAurora, ColoradoLink to downloadable slides:https://bit.ly/4aWn6jhLink to full program:https://bit.ly/4aWBiJ0Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

What this show turned into was God reminding me that there is a reason he had me work in big data and ad tech. We talk about the signs of pure hatred in the elites as they try to censor and shut us up. But then, we get into the infrastructure they have built, including having MIT do things for them., We will go through a Wired article that details how they use ad tech to track us. However, Wired misses the lead. I will show that they are using ad tech to target individuals. And of course, they are using it to censor us. We hear powerful testimony from Dr. Hazen and the censorship that she experienced while trying to save lives during Covid.What does God's Word say? Exodus 4:10-12 10 Moses said to the Lord, “Pardon your servant, Lord. I have never been eloquent, neither in the past nor since you have spoken to your servant. I am slow of speech and tongue.”11 The Lord said to him, “Who gave human beings their mouths? Who makes them deaf or mute? Who gives them sight or makes them blind? Is it not I, the Lord? 12 Now go; I will help you speak and will teach you what to say.”Luke 21:14-15  14 But make up your mind not to worry beforehand how you will defend yourselves. 15 For I will give you words and wisdom that none of your adversaries will be able to resist or contradict.Luke 12:11-12   11 “When you are brought before synagogues, rulers and authorities, do not worry about how you will defend yourselves or what you will say, 12 for the Holy Spirit will teach you at that time what you should say.”Jeremiah 1:9 Then the Lord reached out his hand and touched my mouth and said to me, “I have put my words in your mouth.Psalm 32:8 I will instruct you and teach you in the way you should go;    I will counsel you with my loving eye on you.Episode 1,456 Links:Dr. Sabine Hazan on How Her Clinical Trials on COVID Early Treatment Were Sabotaged During the PandemicDr. Sabine Hazan's Bio is incredibleLiberty University fined record $14 million for campus safety law violationsSend The Police To Intimidate You Neighbor For “WrongSpeak,” Get $2,000 From Taxpayers in “State” [Read: Separate Country] of Washington How the Government Used ‘Track F' to Fund Censorship Tools: Report; The National Science Foundation spent $39 million on Track F, a program related to censoring, suppressing Americans' speech, says a new report.CDC discloses they have at least a dozen medical industry LOBBYING GROUPS, officially SERVING alongside 15 voting members, on ACIP, the supposedly independent vaccine board that just approved the 9th booster shot. CDC list of the ACIP board:4Patriots https://4Patriots.com/Todd Stay connected when the power goes out and get free shipping on orders over $97.   Alan's Soaps https://alanssoaps.com/TODD Use coupon code ‘TODD' to save an additional 10% off the bundle price. Bioptimizers https://bioptimizers.com/todd Use promo code TODD for 10% of your order and get up to 2 travel size bottles of Magnesium Breakthrough free.     Bonefrog  https://bonefrogcoffee.com/todd Use code TODD at checkout to receive 10% off your first purchase and 15% on subscriptions.   Bulwark Capital  Bulwark Capital Management (bulwarkcapitalmgmt.com) Call 866-779-RISK or visit online to get their FREE Common Cents Investing Guide.     GreenHaven Interactive Digital Marketing https://greenhaveninteractive.com Your Worldclass Website Will Get Found on Google! Liver Health https://GetLiverHelp.com/Todd Try Liver Health Formula today and claim your FREE bottle of Nano Powered Omega 3 and bonus gift.  

The Tom Renz Show – Haley dropped out, and McConnell endorsed Trump. Does ANYONE on this planet think that this is genuine? McConnell is holding on to his position until after the election precisely to stab Trump and MAGA in the back. Meanwhile, the CDC is doing what the CDC does - namely, being corrupt. The new ACIP members are simply inexcusable...

The Tom Renz Show – Haley dropped out, and McConnell endorsed Trump. Does ANYONE on this planet think that this is genuine? McConnell is holding on to his position until after the election precisely to stab Trump and MAGA in the back. Meanwhile, the CDC is doing what the CDC does - namely, being corrupt. The new ACIP members are simply inexcusable...

Our guest is Sandra Fryhofer, MD, AMA's liaison to the Advisory Committee on Immunization Practices (ACIP) and a member of ACIP's COVID-19 Vaccine Workgroup. American Medical Association CXO Todd Unger hosts.

Pneumococcal vaccines have been instrumental in decreasing invasive disease since their introduction in the 1980s. 2021 brought regulatory changes and recent ACIP recommendations were published in the Morbidity and Mortality Weekly Report, also known as MMWR. Dr. John Schoen, Senior Clinical Manager of Evidence-Based Medicine and Drug Information shares his insights on these changes with host Gretchen Brummel.      Guest speakers:   John Schoen, PharmD, BCPS Senior Clinical Manager of Evidence-Based Medicine and Drug Information Vizient Center for Pharmacy Practice Excellence      Host:   Gretchen Brummel, PharmD, BCPS   Pharmacy Executive Director   Vizient Center for Pharmacy Practice Excellence     Show Notes:   Recorded in the Fall of 2023 [01:00-03:34] What's new since March 2022 with pneumococcal vaccines  [03:35-06:51] Changes with the adult recommendations [06:52-13:10] New recommendations from CDC as well as published recommendations for adults [13:11-19:05] Recommendations for Pneumococcal vaccines in pediatrics [19:06-21:46] The area of biggest risk moving forward [21:47-24:07] What we are looking at for the future        Links | Resources:   Vizient pneumococcal vaccine side-by-side comparison Click Here ACIP pneumococcal vaccine recommendations Click Here   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Android RSS Feed

Breaking down the new schedule of adult vaccines from the CDC and the recommendations for the COVID, RSV, Mpox vaccines and more. AMA ACIP liaison and AMA's immediate past board chair, Sandra Fryhofer, MD, joins to discuss what has changed and what physicians and patients need to know. American Medical Association CXO Todd Unger hosts.

Nirsevimab is the new FDA-approved monoclonal antibody RSV vaccine for the prevention of severe lower respiratory illness in infants. In this episode, we discuss the current recommendations on who gets the vaccine and when, how to use a lens of health equity to approach the current vaccine shortages, and how to discuss safety and efficacy with vaccine hesitant parents. Now that nirsevimab is on the routine infant immunization schedule, it's extremely important and pediatric providers understand the recommendations and science behind the monoclonal antibody to help vaccine acceptance that will undoubtedly reduce bronchiolitis hospitalization. Instagram: @thepedsnppodcast Show notes and references thepedsnp.com Disclaimer   References: CDC Health Alert Network. (2023). Limited availability of nirsevimab in the United States—Interim CDC recommendations to protect infants from Respiratory Syncytial Virus (RSV) during the 2023–2024 respiratory virus season. Emergency Preparedness and Response. https://emergency.cdc.gov/han/2023/han00499.asp?c Centers for Disease Control and Prevention. (2023). Frequently asked questions about RSV immunization with monoclonal antibody for children 19 months and younger. Vaccines and Preventable Diseases. https://www.cdc.gov/vaccines/vpd/rsv/hcp/child-faqs.html Centers for Disease Control and Prevention. (2022). Vaccines for Children Program. https://www.cdc.gov/vaccines/programs/vfc/index.html Centers for Disease Control and Prevention. (2023). General best practice guidelines for immunization. Vaccine Recommendations and the Guidelines of the ACIP. https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/index.html Jones, J. M., Fleming-Dutra, K. E., Prill, M. M., Roper, L. E., Brooks, O., Sánchez, P. J., Kotton, C. N., Mahon, B. E., Meyer, S., Long, S. S., & McMorrow, M. L. (2023). Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023. MMWR. Morbidity and mortality weekly report, 72(34), 920–925. https://doi.org/10.15585/mmwr.mm7234a4 Hill, D., & Parga-Belinkie, J. (Host). (2023, August 29). Immunizations special: RSV, Covid, pneumococcal disease, influenza (No. 170) [Audio podcast episode]. In Pediatrics on call. American Academy of Pediatrics. www.aap.org/podcast Rha, B., Curns, A. T., Lively, J. Y., Campbell, A. P., Englund, J. A., Boom, J. A., Azimi, P. H., Weinberg, G. A., Staat, M. A., Selvarangan, R., Halasa, N. B., McNeal, M. M., Klein, E. J., Harrison, C. J., Williams, J. V., Szilagyi, P. G., Singer, M. N., Sahni, L. C., Figueroa-Downing, D., McDaniel, D., … Gerber, S. I. (2020). Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016. Pediatrics, 146(1), e20193611. https://doi.org/10.1542/peds.2019-3611 Suh, M., Movva, N., Jiang, X., Bylsma, L. C., Reichert, H., Fryzek, J. P., & Nelson, C. B. (2022). Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009-2019: A Study of the National (Nationwide) Inpatient Sample. The Journal of infectious diseases, 226(Suppl 2), S154–S163. https://doi.org/10.1093/infdis/jiac120

In this episode, Angela Branche, MD, discusses RSV vaccines in older adults, including: Current Advisory Committee on Immunization Practices recommendationsRisk factors associated with severe RSV disease, including RSV-related hospitalizationsApproach to stratifying risk factors (eg, age, comorbidities) in determining which adults may benefit from the RSV vaccine Ongoing research on RSV vaccines in younger adults (eg, aged 40s and 50s years) with chronic comorbidities Health disparities related to RSV vaccinesConsiderations for a risk-based approach, rather than age alone, to determine vaccine candidacy Faculty: Angela Branche, MDAssociate Professor of MedicineDivision of Infectious DiseasesDepartment of MedicineUniversity of RochesterRochester, New YorkLink to full program: https://bit.ly/3nb25xeLink to downloadable slides: https://bit.ly/3TsXym5

In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include:Updated CDC recommendations for one-time universal screening for HBVAddressing patient-, provider-, and system-level barriers to universal HBV screeningBest practices for implementation of HDV screeningPresenters:Douglas Dieterich, MDDirector, Institute for Liver MedicineProfessor of MedicineDivision of Liver DiseasesMount Sinai School of MedicineNew York, New YorkCamilla S. Graham, MD, MPHCo-Director, Viral Hepatitis ClinicDivision of Infectious DiseasesBeth Israel Deaconess Medical CenterHarvard Medical SchoolBoston, MassachusettsRobert Wong, MD, MS Clinical Associate ProfessorDivision of Gastroenterology and HepatologyStanford University School of MedicinePalo Alto, CaliforniaLink to full program:https://bit.ly/3TuqFHILink to the slides: https://bit.ly/4atS42z

In this episode, Helen Y. Chu, MD, MPH, shares updates on RSV seasonality, including: Surveillance limitations due to the testing availability in adultsCurrent 2023/2024 season trends, including predictions for other respiratory viruses (eg, influenza, SARS-CoV-2)Considerations for RSV administrationRSV vaccine coadministration with influenza and COVID-19 vaccinesFaculty:  Helen Y. Chu, MD, MPHAssociate Professor of MedicineDivision of Allergy & Infectious DiseasesUniversity of Washington School of MedicineSeattle, WashingtonLink to full program: https://bit.ly/3nb25xeLink to downloadable slides: https://bit.ly/3TsXym5

In this accredited podcast episode, Dr Christina Madison and Dr Mary Bridgeman discuss the latest practical strategies for preventing RSV infection in older adults, including: Role of basic public health precautionsAvailable and emerging vaccines Mechanisms of action, therapeutic targets, and pharmacologyEfficacy and safety dataFDA approval status and ACIP recommendations Presenters:  Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAPClinical ProfessorErnest Mario School of PharmacyRutgers, The State University of New JerseyPiscataway, New JerseyInternal Medicine PharmacistRobert Wood Johnson University HospitalNew Brunswick, New JerseyChristina M. Madison, PharmD, FCCP, AAHIVP  Clinical PharmacistFounder and CEO, The Public Health Pharmacist, PLLCAdjunct Associate Professor of Pharmacy PracticeRoseman University of Health SciencesCollege of PharmacyHenderson, NevadaOther program activities:  • Frontiers in RSV Prevention for Older Adults: Developments, Recommendations, and the Pharmacist's Role     

Hear from physician experts on strategies to address vaccine hesitancy with patients and updates on current COVID variants, flu, and RSV vaccines. This episode was created in collaboration with the PermanenteDocs Chat podcast, and is hosted by family physician Alex McDonald, MD, featuring guest Sandra Fryhofer, MD, AMA liaison to the CDC's Advisory Committee on Immunization Practices and Immediate Past Chair of the AMA Board of Trustees.

Our hosts discuss the latest news on a federal health care transparency bill and what you need to know this Asthma Peak Week. For the main topic, The Health Advocates break down all that was discussed during the recent Advisory Committee for Immunization Practices (ACIP) meeting about the fall COVID shots. They talk about the recent vaccine approvals, COVID hospitalization rates, long COVID, and vaccine effectiveness. “We learned [during the ACIP meeting] that with hospitalizations, rates across all groups have been rising since July 2023… The most prevalent underlying condition amongst adults ages 18 and older for those who are hospitalized for COVID included cardiovascular disease, neurologic disorders, diabetes, obesity, asthma, and chronic lung disease,” says Zoe Rothblatt, Associate Director of Community Outreach at GHLF. Among the highlights in this episode: 00:38: Steven Newmark, Director of Policy at GHLF, shares that the vote for the PBM Transparency Act, which aims to increase transparency in PBMs to potentially lower health care costs, has been delayed 01:07: Zoe emphasizes the importance of incremental changes in advocacy 02:03: Ahead of Asthma Peak Week, Zoe provides tips for keeping asthma under control, emphasizing prevention, communication, and the importance of staying updated on vaccinations 03:06: Zoe shares insights from a recent ACIP meeting on the COVID vaccines, including remarks from the CDC director, Dr. Mandy Cohen, who commented on the current state of the pandemic and the tools available to combat various viruses 04:26: Our hosts discuss the renaming of the COVID vaccine from "booster shot" to "23-24 mRNA COVID-19 vaccine" 05:01: Steven elaborates on the specific features of the new COVID vaccine, who it's recommended for, and the shift from the previously used vaccine 06:17: The health advocates discuss the current state of the COVID pandemic, with a focus on hospitalizations, long COVID, and vaccine effectiveness 06:33: Zoe delves into the data presented during the vaccine meeting, particularly concerning hospitalizations among people with chronic conditions 08:16: Zoe provides details on the prevalence and impact of long COVID on various age groups, noting the significant limitations it imposes on daily life for many 10:41: Steven shares resources on where listeners can find a COVID vaccine near them, and reminds them to check insurance coverage when getting the vaccine To find a COVID vaccine near you, you can visit www.vaccines.gov   11:00: Our hosts wrap up by addressing options for uninsured listeners, pointing them toward specific programs and resources 11:32: What our hosts learned from this episode Contact Our Hosts Steven Newmark, Director of Policy at GHLF: snewmark@ghlf.org Zoe Rothblatt, Associate Director, Community Outreach at GHLF: zrothblatt@ghlf.org We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.org Catch up on all our episodes on our website or on your favorite podcast channel.See omnystudio.com/listener for privacy information.

In this episode, Angela Branche, MD, discusses the Advisory Committee on Immunization Practices recommendations for RSV vaccines in older adults, including: Use of shared clinical decision-making How to approach the conversation about the RSV vaccine with patientsKey populations who may benefit the most, such as those at risk for severe RSV disease (eg, increasing age and persons who are frail or have cardiopulmonary comorbidities)Faculty: Angela Branche, MDAssociate Professor of MedicineDivision of Infectious DiseasesDepartment of MedicineUniversity of RochesterRochester, New YorkLink to full program: https://bit.ly/3nb25xeLink to downloadable slides: https://bit.ly/3nb25xe

Title: New RSV Monoclonal Antibody and Vaccine Conversation   Target Audience This activity is directed to physicians who take care of hospitalized children, medical students, nurse practitioners, and physician assistants working in the emergency room, intensive care unit, or hospital wards.   Objectives: Upon completion of this activity, participants should be able to: Review how monoclonal antibodies work in fightin disease.  Review Nirsevimab and the ACIP and AAP reccomendations for its use.  Discuss how monoclonal antibodies are different from vaccines and discuss the new RSV vaccines being released.  Faculty:  Planning Committee: Maha Kaissi, MD, MHPE — Assistant Professor of Pediatrics, Division of Pediatric Hospital Medicine, UPMC Children's Hospital of Pittsburgh   Course Directors: Tony R. Tarchichi MD — Assistant Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C. Gaffney Division of Pediatric Hospital Medicine Dr. Tarchichi has disclosed he was a member of the Advisory Board for meningococcal vaccine in immunocompromised patient for Sanofi Corp   John Williams, MD —  Professor in the Dept. of Pediatrics at the University of Pittsburgh, Division Director for Pediatric Infectious Disease Division at University of Pittsburgh Medical Center (UPMC).   Conflict of Interest Disclosure: No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.   Accreditation Statement: In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.   The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.   Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.   Disclaimer Statement: The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.   Released 8/29/2023,  Expires 8/29/2026   The direct link to the course is provided below: COMING SOON!!

New internal CDC emails, obtained through FOIA by ICAN's legal team, reveal CDC leadership appearing to respond exuberantly to the deplatforming of Del Bigtree and The HighWire.#Deplatformed #ACIP #CDC #TheHighWire #DelBigtree #Censorship #FreeSpeech